|
Re: must read article --should her2+ breast cancer be divided into ER+ vs ER- subtype
Europa,
Rhondalea posted on Feb 1 about a test to see if you're a poor, intermediate, or extensive metabolizer and had information on a website-maybe she can add more info. Discuss with your onc the results, if any, on the Suppression of Ovarion Function Trial (SOFT) and if he/she is open to the test for CYP2D6. That is the test I asked to have, but was told it isn't proven, however it is now in a clinical trial at the BC Cancer Agency.
Before you get too far into the Tamoxifen treatment, since you have just finished Herceptin, ask to have your hormone levels checked as a baseline, and have them checked every 3 months. I think Becky suggested that in one of her posts. See if your onc is also open to you having your TM's checked.
__________________
Dx Age 47 July/09 Stage 2B/3
Left Mast. Aug 09- 1 of 3 positive nodes in axillary dissection (yes only 3)
ER+ 90%, PR+ 20%, HER2+++
4 x AC, 4 x Paclitaxol and H (Neupogen for 7 cycles), Herceptin complete Nov 10
Mar–Apr 2010 25 Rads
Apr 10-Oct 11- Tamoxifen
Oct 11 – 3 cm met to sternum
Oct 11-Letrozole for 3 mths, start Clasteon-bone remodeller
Nov-Dec 11 - Happy 50th Birthday -20 rads to sternum
Jan-April 2012 Taxotere/Herceptin-6 cycles (Neupogen for 5)
Herceptin every 3 weeks-Letrozole added Nov 2012
|